4//SEC Filing
Rice Steven J. 4
Accession 0001209191-21-053237
CIK 0001706431other
Filed
Aug 23, 8:00 PM ET
Accepted
Aug 24, 6:44 PM ET
Size
8.8 KB
Accession
0001209191-21-053237
Insider Transaction Report
Form 4
Rice Steven J.
Chief Administrative Officer
Transactions
- Sale
Common Stock
2021-08-23$50.00/sh−10,000$500,000→ 20,000 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2021-08-23−10,000→ 434,441 totalExercise: $12.76Exp: 2029-12-10→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2021-08-23$12.76/sh+10,000$127,600→ 30,000 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021.
- [F2]1/4 of the shares subject to the stock option vest and become exercisable on September 15, 2020, and the remainder vest in 36 equal monthly installments thereafter.
Documents
Issuer
Vir Biotechnology, Inc.
CIK 0001706431
Entity typeother
Related Parties
1- filerCIK 0001820108
Filing Metadata
- Form type
- 4
- Filed
- Aug 23, 8:00 PM ET
- Accepted
- Aug 24, 6:44 PM ET
- Size
- 8.8 KB